View of ADVANCED NANOTHERAPEUTICS IN MULTIPLE SCLEROSIS TREATMENT: FROM BLOOD-BRAIN BARRIER CROSSING TO REMYELINATION ENHANCEMENT | International Journal of Applied Pharmaceutics